SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stan s. who wrote (64504)1/20/2000 6:44:00 AM
From: stan s.  Read Replies (1) of 108040
 
VVUS, VIVUS Announces Higher Than Expected Fourth Quarter Earnings Per Share
Company Expects To Report Between $0.40 and $0.42 EPS
MOUNTAIN VIEW, Calif.--(BW HealthWire)--Jan. 20, 2000--VIVUS, Inc. (Nasdaq:VVUS - news) today announced that the Company expects to report earnings per share (''EPS'') between $0.40 and $0.42 for its fourth quarter of 1999. The increase in EPS is primarily due to additional revenues recorded as part of the resolution of financial obligations related to the return to VIVUS of marketing and distribution rights for MUSE® (alprostadil) from AstraZeneca.

Complete details of the Company's quarterly and year end financial results will be available in a press release to be issued on January 26, 2000 at the close of market. VIVUS invites shareholders and the financial community to participate in its conference call which will be held at 4:30 p.m. Eastern Time on January 26, 2000. The call can be accessed via a live webcast on the Internet at www.vcall.com or www.streetfusion.com....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext